Home NDC 74866-414-03 SUAVECITO 5% Minoxidil Solution
Product NDC 74866-414
Requested package NDC 74866-414-03
11-digit product format 748660414
Labeler code 74866
Product ID 74866-414_00bf0083-4ef5-76ef-e063-6294a90a9907
Type HUMAN OTC DRUG
Nonproprietary name MINOXIDIL
Dosage form LIQUID
Route TOPICAL
Labeler SUAVECITO, INC.
Application ANDA076239
Marketing category ANDA
Marketing start 2023-07-31
Substance MINOXIDIL
Active strength 50 mg/mL
Pharmacologic classes Arteriolar Vasodilation [PE], Arteriolar Vasodilator [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 43 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A076239-001 THEROXIDIL MINOXIDIL 5% SOLUTION / TOPICAL 2004-08-24
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-09-14 22:38:34 2026-08 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 84e616aacf4f…2026-08-18 06:07:40 2026-07 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A076239-001 THEROXIDIL 5% SOLUTION / TOPICAL 2004-08-24 f41ea6bd6efb…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
Finished product Yes
Brand name base SUAVECITO 5% Minoxidil Solution
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MINOXIDIL 50 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 5965120SH1 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 311724 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 74866-414-01 SUAVECITO 5% Minoxidil Solution 60 mL in 1 BOTTLE LIQUID 60 1 74866-414-01 SUAVECITO 5% Minoxidil Solution 1 in 1 BOX LIQUID 1 1 74866-414-03 SUAVECITO 5% Minoxidil Solution 60 mL in 1 BOTTLE LIQUID 60 1 74866-414-03 SUAVECITO 5% Minoxidil Solution 3 in 1 BOX LIQUID 3 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 74866-414 SUAVECITO 5% MINOXIDIL SOLUTION (MINOXIDIL) LIQUID [SUAVECITO, INC.] 1 Current NDC, 4 package rows 20230731_a6d3c488-f943-4edf-9d6b-21a3dee92d78.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 2 · 31 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 74866-414-03 74866041403 3 BOTTLE in 1 BOX (74866-414-03) / 60 mL in 1 BOTTLE 3 bottle 2023-07-31 No No Current